The HTG EdgeSeq processor, assays, and parser software facilitate analysis of gene expression profiles from a wide variety of specimen types to accelerate discovery, support translational applications and evaluate target biomarkers for companion diagnostics.
Our extraction-free specimen preparation and quantitative nuclease protection chemistry assays automate preparation of mRNA and miRNA targets for library preparation and next-generation sequencing (NGS) analysis.
HTG's solutions enable fast, reliable, reproducible, and quantitative analysis of thousands of targeted RNAs from a single assay in as little as 36 hours with reduced hands-on time from sample prep through data analysis.
HTG‘s extraction-free chemistry reduces sample input requirements and preserves valuable specimens. The HTG EdgeSeq chemistry eliminates timely and technically challenging steps - cDNA synthesis, size selection, rRNA depletion, end repair, and adapter ligation. HTG leverages the power of NGS and yields aligned data that accurately and reproducibly quantitates gene expression profiles.
When placing an order, please specify the catalog number:
HTG EDGE-SQ-100 HTG EdgeSeq system
HTG EDGE-SQ-100E HTG EdgeSeq system CE-IVD
HTG EDGE-SP-010 HTG EdgeSeq processor
HTG EDGE-PC-001 HTG Edge system PC, algorithm, accessories
Learn more about the HTG EdgeSeq system.
HTG EdgeSeq System Product Sheet
Download pdf 283KB
HTG EdgeSeq System Workflow
Watch Now
HTG EdgeSeq System Workflow Brochure
Download pdf 370KB
The Advantages of HTG EdgeSeq System & Chemistry
Download pdf 230KB
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Download pdf 1.0MB
Comparison of HTG-edge targeted RNA sequencing platform with whole transcriptome RNA sequencing for clinical biomarker studies
Download pdf 249KB
View External Link
Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin-Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform
View External Link
Molecular profiling of small cell bladder cancer (SCBC) to reveal gene expression determinants of an aggressive phenotype
Download pdf 2.4MB
Molecular characterization of immune-related severe adverse events (irSAE)
Download pdf 1.0MB
A Cross Comparison of Technologies for the Detection of Immune System Related Gene Expression Signatures in Clinical FFPE Samples of Metastatic Prostate Cancer Patients
Download pdf 2.2MB
Validation of our HTG EdgeSeq Platform for accurate and sensitive biomarker discovery
Download pdf 3.2MB
Unique Endogenous Controls for Extraction-Free Targeted RNA Sequencing Assays
Download pdf 2.2MB
New tools for Biomarker Discovery Promise Personalized Treatment for Rheumatoid Arthritis
View Webinar
For more information about the HTG EdgeSeq system, please fill out the form below. Or call us at (877) 507-3259.
Page last updated March 10, 2020